Ventripoint Diagnostics Stock Analysis
| VPT Stock | CAD 0.14 0.01 6.67% |
VentriPoint Diagnostics is overvalued with Real Value of 0.12 and Hype Value of 0.15. The main objective of VentriPoint Diagnostics stock analysis is to determine its intrinsic value, which is an estimate of what VentriPoint Diagnostics is worth, separate from its market price. There are two main types of VentriPoint Diagnostics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect VentriPoint Diagnostics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of VentriPoint Diagnostics' stock to identify patterns and trends that may indicate its future price movements.
The VentriPoint Diagnostics stock is traded in Canada on TSX Venture Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. VentriPoint Diagnostics is usually not traded on Family Day, Good Friday, Victoria Day, Canada Day, Civic Holiday, Labour Day, Christmas Day, Boxing Day, New Year 's Day. VentriPoint Stock trading window is adjusted to America/Toronto timezone.
VentriPoint |
VentriPoint Stock Analysis Notes
The company recorded a loss per share of 0.03. VentriPoint Diagnostics had not issued any dividends in recent years. The entity had 1:10 split on the 7th of December 2015. Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease primarily in Canada, the United States, and Europe. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart diseases, left or right heart failure, and normal hearts. VENTRIPOINT DIAGNOSTICS operates under Diagnostics Research classification in Canada and is traded on TSX Venture Exchange. For more information please call BASc ICDD at 416 848 4156 or visit https://ventripoint.com.VentriPoint Diagnostics Investment Alerts
| VentriPoint Diagnostics had very high historical volatility over the last 90 days | |
| VentriPoint Diagnostics has some characteristics of a very speculative penny stock | |
| VentriPoint Diagnostics has high likelihood to experience some financial distress in the next 2 years | |
| VentriPoint Diagnostics has accumulated 1.36 M in total debt. VentriPoint Diagnostics has a current ratio of 0.55, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist VentriPoint Diagnostics until it has trouble settling it off, either with new capital or with free cash flow. So, VentriPoint Diagnostics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like VentriPoint Diagnostics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for VentriPoint to invest in growth at high rates of return. When we think about VentriPoint Diagnostics' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 95.17 K. Net Loss for the year was (4.92 M) with profit before overhead, payroll, taxes, and interest of 166.49 K. | |
| VentriPoint Diagnostics has accumulated about 713.21 K in cash with (3.39 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Latest headline from news.google.com: Ventripoint Diagnostics to Issue Shares for Debenture Interest Payment - TipRanks |
VentriPoint Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 24.9 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate VentriPoint Diagnostics's market, we take the total number of its shares issued and multiply it by VentriPoint Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.VentriPoint Profitablity
VentriPoint Diagnostics' profitability indicators refer to fundamental financial ratios that showcase VentriPoint Diagnostics' ability to generate income relative to its revenue or operating costs. If, let's say, VentriPoint Diagnostics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, VentriPoint Diagnostics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of VentriPoint Diagnostics' profitability requires more research than a typical breakdown of VentriPoint Diagnostics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (7.48) | (7.85) | |
| Return On Capital Employed | 1.73 | 0.91 | |
| Return On Assets | (7.48) | (7.85) | |
| Return On Equity | 1.65 | 1.73 |
Management Efficiency
VentriPoint Diagnostics has return on total asset (ROA) of (3.2145) % which means that it has lost $3.2145 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (29.726) %, meaning that it generated substantial loss on money invested by shareholders. VentriPoint Diagnostics' management efficiency ratios could be used to measure how well VentriPoint Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to climb to 1.73 in 2025, whereas Return On Tangible Assets are likely to drop (7.85) in 2025. At this time, VentriPoint Diagnostics' Non Currrent Assets Other are fairly stable compared to the past year. Other Current Assets is likely to climb to about 73.8 K in 2025, whereas Total Current Assets are likely to drop slightly above 450.6 K in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | (0.02) | (0.02) | |
| Net Current Asset Value | 771 K | 751.2 K | |
| Tangible Asset Value | 771 K | 751.2 K | |
| Tangible Book Value Per Share | (0.02) | (0.02) | |
| Enterprise Value Over EBITDA | (3.66) | (3.84) | |
| Price Book Value Ratio | (5.31) | (5.04) | |
| Enterprise Value Multiple | (3.66) | (3.84) | |
| Price Fair Value | (5.31) | (5.04) | |
| Enterprise Value | 17.4 M | 10.4 M |
Leadership effectiveness at VentriPoint Diagnostics is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 21st of July, VentriPoint Diagnostics has the Semi Deviation of 4.49, coefficient of variation of 2086.77, and Risk Adjusted Performance of 0.0535. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of VentriPoint Diagnostics, as well as the relationship between them. Please validate VentriPoint Diagnostics variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if VentriPoint Diagnostics is priced more or less accurately, providing market reflects its prevalent price of 0.14 per share.VentriPoint Diagnostics Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of VentriPoint Diagnostics for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out VentriPoint Diagnostics short-term fluctuations and highlight longer-term trends or cycles.
VentriPoint Diagnostics Outstanding Bonds
VentriPoint Diagnostics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. VentriPoint Diagnostics uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most VentriPoint bonds can be classified according to their maturity, which is the date when VentriPoint Diagnostics has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
VentriPoint Diagnostics Predictive Daily Indicators
VentriPoint Diagnostics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of VentriPoint Diagnostics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 10200.0 | |||
| Daily Balance Of Power | (1.00) | |||
| Rate Of Daily Change | 0.93 | |||
| Day Median Price | 0.15 | |||
| Day Typical Price | 0.14 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
VentriPoint Diagnostics Forecast Models
VentriPoint Diagnostics' time-series forecasting models are one of many VentriPoint Diagnostics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary VentriPoint Diagnostics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About VentriPoint Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how VentriPoint Diagnostics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling VentriPoint shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as VentriPoint Diagnostics. By using and applying VentriPoint Stock analysis, traders can create a robust methodology for identifying VentriPoint entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (52.57) | (55.20) | |
| Operating Profit Margin | (50.45) | (52.98) | |
| Net Loss | (51.69) | (54.28) | |
| Gross Profit Margin | 0.78 | 0.82 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding VentriPoint Diagnostics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
Additional Tools for VentriPoint Stock Analysis
When running VentriPoint Diagnostics' price analysis, check to measure VentriPoint Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VentriPoint Diagnostics is operating at the current time. Most of VentriPoint Diagnostics' value examination focuses on studying past and present price action to predict the probability of VentriPoint Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VentriPoint Diagnostics' price. Additionally, you may evaluate how the addition of VentriPoint Diagnostics to your portfolios can decrease your overall portfolio volatility.